Trilliome wins 1st prize in EIT Food’s “Food as Medicine” accelerator

Swiss startup Trilliome has won first prize in the EIT Food Accelerator Network’s “Food as Medicine” programme, receiving €50,000 in Tech Validation Funding.

The award supports the company’s mission to develop precision bioactives that reprogram the gut microbiome to restore brain and immune health for healthy aging. The funding will accelerate validation of Trilliome’s AI-driven discovery platform, which transforms upcycled plant sources into targeted gut bioactives that promote resilience and wellbeing.

A milestone year for Trilliome

2025 marks a breakthrough year for the Lausanne-based company. In addition to winning EIT Food’s top accelerator prize, Trilliome also earned second prize at the Aging Research and Drug Discovery (ARDD) Conference – one of the world’s leading events in longevity science – and the Probiota Americas Pioneer Prize for innovation in the microbiome field.

These achievements position Trilliome at the intersection of biotechnology, nutrition, and healthy aging, validating its science-led approach to redefining how food and bioactives can drive measurable health outcomes.

Turning plant waste into human health

Trilliome’s proprietary AI and human gut model platform identifies molecular combinations that reprogramme the microbiome, boosting keystone bacterial species and restoring functions linked to brain and immune health.

The company’s lead bioactive product is derived from upcycled fruit and plant waste streams, supporting both human health and planetary sustainability. Early studies in human models show increased levels of beneficial gut bacteria and higher production of short-chain fatty acids such as butyrate and propionate, key compounds for cognitive health, mood regulation, and immune balance.

Accelerating toward measurable impact

The EIT Food Tech Validation Award provides critical support as Trilliome advances toward clinical validation, scalable manufacturing, and regulatory readiness. These steps will help bring its innovations to market and enable new partnerships across the ingredients, supplements, and medical foods sectors.

Together with its partners and mentors, Trilliome is working to build a future where nutrition and biotechnology converge to deliver measurable health outcomes and promote healthy longevity.

Sign up to receive the Valley’s quarterly newsletter 

Latest News